# Arkal Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arkal-medical

- Industry: Medical Devices & Equipment
- Headquarters: Fremont, US
- Website: www.arkalmedical.com
- Total disclosed funding: $23M
- Latest round: Series B (Sep 16, 2008)
- Investors on record: 3

## About

Arkal Medical specializes in providing advanced medical devices and solutions. Their expertise lies in innovative healthcare technologies designed to enhance patient care and operational efficiency in medical environments.Arkal Medical develops medical devices aimed at improving healthcare delivery. The company has evolved its business strategy over time to focus on innovative solutions in the healthcare sector. Based in Fremont, US, Arkal Medical was founded by Arvind Jina, who has a history of establishing companies in the medical technology field. The company has raised a total of USD 17.5 mn, with the latest funding being a Series B round, where they secured USD 17.5 mn from investors including Thomas, McNerney & Partners, Delphi Ventures, and MedVenture Associates.Arkal Medical offers a range of medical devices and healthcare solutions that focus on improving patient outcomes and operational workflows in clinical settings. Their products include advanced diagnostic tools and treatment equipment designed for various medical applications. The company caters to healthcare providers across North America, Europe, and Asia, meeting diverse market needs through tailored product offerings.The revenue model of Arkal Medical is largely based on direct sales of medical devices, with clients purchasing products that align with their healthcare needs. This model fosters long-term relationships with healthcare institutions as they rely on Arkal Medical for essential medical technologies. The company's flagship products are competitively priced within the market, emphasizing their advanced features and reliable support services.In September 2008, Arkal Medical raised USD 17.5 mn in Series B financing to support the development of new medical devices and expand into emerging markets. The company plans to launch new innovative products aimed at enhancing patient care by the end of 2009. Additionally, there are strategic initiatives to enter the Asian healthcare market, targeting countries such as India and China by mid-2010, utilizing the recent funding to bolster research and development efforts.

## Funding rounds

- Series B, Sep 16, 2008, $18M — Delphi Ventures, MedVenture Associates, Thomas, McNerney & Partners
- Series A, Jan 5, 2006, $5.3M — Delphi Ventures, MedVenture Associates

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series B
- MedVenture Associates (https://capitalatlas.ai/funds/medventure-associates) — Series A, Series B
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series B